Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00294
Full Text
Open PDFAbstract
Available in full text
Date
February 26, 2019
Authors
Publisher
Frontiers Media SA